Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Novavax, Inc. (NVAX)

« Back to company index

NVAX Chatter Timeline

Stock Ticker for NVAX

Most Active Tweeters for NVAX

UserTweets
@Tickeron 13
@tabuhasna 11
@AmericanBanking 5
@TranscriptDaily 5
@ZolmaxNews 3

Recent Tweets for NVAX

tabuhasna @tabuhasna
RT @OlympiaReport: $4.40 Million in Sales Expected for Novavax, Inc. $NVAX This Quarter https://t.co/Z4SBLBgJKj
October 21st 2019, 5:10pm
TheMarketsDaily @TheMarketsDaily
-$0.91 EPS Expected for Novavax, Inc. $NVAX This Quarter https://t.co/KQtw50ew1I
October 21st 2019, 2:10pm
OlympiaReport @OlympiaReport
$4.40 Million in Sales Expected for Novavax, Inc. $NVAX This Quarter https://t.co/Z4SBLBgJKj
October 21st 2019, 2:10pm
stocknewstimes @stocknewstimes
Analysts Expect Novavax, Inc. $NVAX Will Post Earnings of -$0.91 Per Share https://t.co/6exVFJppez
October 21st 2019, 2:10pm
dispatchtribune @dispatchtribune
Brokerages Anticipate Novavax, Inc. $NVAX Will Post Quarterly Sales of $4.40 Million https://t.co/paLSj1Wf85
October 21st 2019, 2:10pm
BlueBioNow @BlueBioNow
$NVAX here we go!! -3.02 % change recently https://t.co/Dn4wf0P8Iq
October 21st 2019, 9:10am
Tickeron @Tickeron
$NVAX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/GHppYNBKPD
October 21st 2019, 4:10am
tabuhasna @tabuhasna
RT @OlympiaReport: Cantor Fitzgerald Reiterates “Neutral” Rating for Novavax $NVAX https://t.co/yBiC0V8oHM
October 21st 2019, 3:10am
tabuhasna @tabuhasna
RT @bbnsnews: Cantor Fitzgerald Reiterates “Neutral” Rating for Novavax $NVAX https://t.co/mw0fzBOaFb
October 21st 2019, 3:10am
bbnsnews @bbnsnews
Cantor Fitzgerald Reiterates “Neutral” Rating for Novavax $NVAX https://t.co/mw0fzBOaFb
October 21st 2019, 3:10am
OlympiaReport @OlympiaReport
Cantor Fitzgerald Reiterates “Neutral” Rating for Novavax $NVAX https://t.co/yBiC0V8oHM
October 21st 2019, 3:10am
macondailynews @macondailynews
Zacks Investment Research Lowers Novavax $NVAX to Sell https://t.co/sRv4nsGXLZ
October 21st 2019, 2:10am
dakotafinancial @dakotafinancial
Novavax $NVAX Stock Rating Lowered by Zacks Investment Research https://t.co/iMMD1J5wAF
October 21st 2019, 2:10am
TranscriptDaily @TranscriptDaily
Novavax, Inc. Forecasted to Post FY2019 Earnings of -$5.60 Per Share $NVAX https://t.co/xZT5YtXgGQ
October 21st 2019, 2:10am
stocknewstimes @stocknewstimes
Novavax, Inc. Forecasted to Post FY2019 Earnings of -$5.60 Per Share $NVAX https://t.co/o5eKXMT953
October 21st 2019, 2:10am
RatingsNetwork @RatingsNetwork
Cantor Fitzgerald Sets Novavax FY2019 Earnings Estimates at ($5.60) EPS. https://t.co/3xTa2F52jj $NVAX #NVAX
October 21st 2019, 2:10am
AmericanBanking @AmericanBanking
Novavax, Inc. Forecasted to Post FY2019 Earnings of -$5.60 Per Share $NVAX https://t.co/8vuhayNpyT #stocks
October 21st 2019, 2:10am
TranscriptDaily @TranscriptDaily
Novavax $NVAX Rating Lowered to Sell at Zacks Investment Research https://t.co/gl8dYSjfgv
October 20th 2019, 12:10pm
stocknewstimes @stocknewstimes
Novavax $NVAX Downgraded by Zacks Investment Research to “Sell” https://t.co/v3yt1vCOku
October 20th 2019, 12:10pm
Tickeron @Tickeron
$NVAX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/1y6WUJ4kbr
October 20th 2019, 4:10am
hzaben @hzaben
$NVAX 30 min chart. double bottom. may have finally found support at 4.40 https://t.co/m7bY1ybjrd
October 20th 2019, 3:10am
ZolmaxNews @ZolmaxNews
Q3 2019 EPS Estimates for Novavax, Inc. Reduced by Analyst $NVAX https://t.co/AqFUo5N7Ku
October 20th 2019, 1:10am
TranscriptDaily @TranscriptDaily
Novavax $NVAX Receives Neutral Rating from Cantor Fitzgerald https://t.co/lcsuPV5pMr
October 20th 2019, 1:10am
dispatchtribune @dispatchtribune
Novavax $NVAX Stock Rating Reaffirmed by Cantor Fitzgerald https://t.co/Bb75j0ijIe
October 19th 2019, 2:10pm
WeekHerald @WeekHerald
Novavax’s $NVAX “Neutral” Rating Reaffirmed at Cantor Fitzgerald https://t.co/v2McPlB3go
October 19th 2019, 2:10pm
ThisLincolnian @ThisLincolnian
Novavax’s $NVAX “Neutral” Rating Reaffirmed at Cantor Fitzgerald https://t.co/pJ9D3oGbYo
October 19th 2019, 2:10pm
AmericanBanking @AmericanBanking
Novavax $NVAX Rating Reiterated by Cantor Fitzgerald https://t.co/QSr0bEizmw #stocks
October 19th 2019, 8:10am
Tickeron @Tickeron
$NVAX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/xevy4d1ARz
October 19th 2019, 7:10am
ZolmaxNews @ZolmaxNews
Analysts Anticipate Novavax, Inc. $NVAX to Post -$0.91 Earnings Per Share https://t.co/7Sv9kIpjM7
October 19th 2019, 7:10am
TickerReport @TickerReport
Oppenheimer Equities Analysts Decrease Earnings Estimates for Novavax, Inc. $NVAX https://t.co/nJQHKqY3aD
October 19th 2019, 1:10am
dailypoliticaln @dailypoliticaln
Oppenheimer Equities Analysts Decrease Earnings Estimates for Novavax, Inc. $NVAX https://t.co/CgN6F0VyM4
October 19th 2019, 1:10am
gcassidy718 @gcassidy718
$NVAX significant stock price movement -3.24 % change recently https://t.co/P7uqhyOOBU
October 18th 2019, 3:10pm
Tickeron @Tickeron
$NVAX in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/advh8BFVK6
October 18th 2019, 10:10am
AmericanBanking @AmericanBanking
Analysts Offer Predictions for Novavax, Inc.’s Q3 2019 Earnings $NVAX https://t.co/z8kXVvBXQ4 #stocks
October 18th 2019, 6:10am
registrarjourn @registrarjourn
Analysts Offer Predictions for Novavax, Inc.’s Q3 2019 Earnings $NVAX https://t.co/AggQuRhzxN
October 18th 2019, 6:10am
EnterpriseLeade @EnterpriseLeade
Analysts Offer Predictions for Novavax, Inc.’s Q3 2019 Earnings $NVAX https://t.co/usNWsZRBY2
October 18th 2019, 6:10am
TranscriptDaily @TranscriptDaily
Analysts Offer Predictions for Novavax, Inc.’s Q3 2019 Earnings $NVAX https://t.co/Z0jOFjCbse
October 18th 2019, 6:10am
tabuhasna @tabuhasna
RT @AmericanBanking: Analysts Expect Novavax, Inc. $NVAX Will Post Quarterly Sales of $4.40 Million https://t.co/7MXuqmyeg0 #stocks
October 18th 2019, 6:10am
tabuhasna @tabuhasna
RT @dakotafinancial: Zacks: Brokerages Expect Novavax, Inc. $NVAX Will Announce Quarterly Sales of $4.40 Million https://t.co/0w0jf1IVg1
October 18th 2019, 6:10am
dakotafinancial @dakotafinancial
Zacks: Brokerages Expect Novavax, Inc. $NVAX Will Announce Quarterly Sales of $4.40 Million https://t.co/0w0jf1IVg1
October 18th 2019, 3:10am
AmericanBanking @AmericanBanking
Analysts Expect Novavax, Inc. $NVAX Will Post Quarterly Sales of $4.40 Million https://t.co/7MXuqmyeg0 #stocks
October 18th 2019, 3:10am
Tickeron @Tickeron
$NVAX in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators:… https://t.co/YTtBsz7UlY
October 17th 2019, 6:10am
TranscriptDaily @TranscriptDaily
Novavax, Inc. $NVAX Expected to Announce Earnings of -$0.88 Per Share https://t.co/GpCfEBGEr8
October 16th 2019, 1:10pm
registrarjourn @registrarjourn
Analysts Anticipate Novavax, Inc. $NVAX to Announce -$0.88 Earnings Per Share https://t.co/nHGQTuHw0i
October 16th 2019, 1:10pm
EnterpriseLeade @EnterpriseLeade
Analysts Anticipate Novavax, Inc. $NVAX to Announce -$0.88 Earnings Per Share https://t.co/skJvtoFWRA
October 16th 2019, 1:10pm
AmericanBanking @AmericanBanking
Novavax, Inc. $NVAX Expected to Announce Earnings of -$0.88 Per Share https://t.co/ALwujFTo22 #stocks
October 16th 2019, 1:10pm
Tickeron @Tickeron
$NVAX's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/1DZe7xiqUG
October 16th 2019, 6:10am
tabuhasna @tabuhasna
RT @catfish456: NVAX - 4.69 Pre-market now at 4.69/4.84 Novavax Initiates Pivotal Phase 3 Clinical Trial of NanoFlu Influenza $NVAX https…
October 15th 2019, 10:10am
tabuhasna @tabuhasna
RT @TekATL3: $NVAX initiates ph 3
October 15th 2019, 7:10am
tabuhasna @tabuhasna
RT @ez_alertz: $NVAX Novavax kicks off late-stage trial for new seasonal flu vaccine https://t.co/NiJ2lah8wj
October 15th 2019, 7:10am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.